Life Science Investing Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
Life Science Investing Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress
Life Science Investing Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer 2025 Spring Scientific Meeting
